- Home
- UBCP vs PLRX Comparison
UBCP vs PLRX Comparison
Compare UBCP & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBCP | PLRX |
|---|---|---|
| Founded | 1902 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 74.9M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | UBCP | PLRX |
|---|---|---|
| Price | $15.99 | $1.14 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.67 |
| AVG Volume (30 Days) | 9.3K | ★ 440.2K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.73% | N/A |
| EPS Growth | 5.51 | ★ 29.97 |
| EPS | ★ 0.33 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.58 | N/A |
| P/E Ratio | $48.45 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.47 | $1.09 |
| 52 Week High | $17.34 | $1.95 |
Technical Indicators
Market Signals| Indicator | UBCP | PLRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.18 | 45.61 |
| Support Level | $14.86 | $1.14 |
| Resistance Level | $16.12 | $1.37 |
| Average True Range (ATR) | 0.37 | 0.05 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 73.88 | 28.57 |
Price Performance
Historical ComparisonAbout UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.